ArticleOncoTargets and therapy2019
Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma.
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 32 citations in OpenAlex.
- Dehydrocorydaline Accelerates Palatal Wound Healing in Mice Through Suppression of the p38 MAPK/CCL2 Axis and Macrophage Chemotaxis: A Preliminary Study.Biomedicines · 2026Article
- The Oncogenic Role of Prostate Stem Cell Antigen (PSCA) in Colorectal Cancer: Implications for Targeted Therapy.Current issues in molecular biology · 2026Article
- Orosomucoid 1 interacts with S100A12 and activates ERK signalling to expedite the advancement of bladder cancer.Cell adhesion & migration · 2025Article
- RNA mCancer communications (London, England) · 2025Article
- FABP4 Downregulated by FOS Alleviates Palmitic Acid-induced Endothelial Cell Dysfunction Via Inactivating ERK/STAT-1 Signaling Pathway.Cell biochemistry and biophysics · 2025Article
- Research Progress of Natural Compounds from Chinese Herbal Medicine in the Treatment of Melanoma.Current treatment options in oncology · 2025Review
- Dehydrocorydaline maintains the vascular smooth muscle cell contractile phenotype by upregulating Spta1.Acta pharmacologica Sinica · 2025Article
- Dehydrocorydaline attenuates bleomycin-induced pulmonary fibrosis by inhibiting fibroblast activation.Respiratory research · 2025Article
- Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals.Cancer metastasis reviews · 2024Review
- Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review.Cancer metastasis reviews · 2024Review
- Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-ERK Signaling Pathway in Endometrial Cancer Cells.Molecules (Basel, Switzerland) · 2024Article
- Silencing LY6D Expression Inhibits Colon Cancer in Xenograft Mice and Regulates Colon Cancer Stem Cells' Proliferation, Stemness, Invasion, and Apoptosis via the MAPK Pathway.Molecules (Basel, Switzerland) · 2023Article
- Dehydrocorydaline Accelerates Cell Proliferation and Extracellular Matrix Synthesis of TNFα-Treated Human Chondrocytes by Targeting Cox2 through JAK1-STAT3 Signaling Pathway.International journal of molecular sciences · 2022Article
- CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism.Frontiers in oncology · 2022Article
- Melatonin inhibits gallbladder cancer cell migration and invasion via ERK-mediated induction of epithelial-to-mesenchymal transition.Oncology letters · 2021Article
- Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis.Molecular therapy oncolytics · 2021Article
- Dehydrocorydaline Protects Against Sepsis-Induced Myocardial Injury Through Modulating the TRAF6/NF-κB Pathway.Frontiers in pharmacology · 2021Article
- Lycorine hydrochloride inhibits melanoma cell proliferation, migration and invasion via down-regulating p21American journal of cancer research · 2021Article
- The Vital Roles of LINC00662 in Human Cancers.Frontiers in cell and developmental biology · 2021Review
- miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1.Renal failure · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
14 authors at 2 institutions in 1 country.
Huanrong HuDepartment of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang 050000, People's Republic of China.
Zhen DongState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, People's Republic of China.
Xianxing WangState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, People's Republic of China.
Longchang BaiState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, People's Republic of China.
Qian LeiState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, People's Republic of China.
Jie YangState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, People's Republic of China.
Lin LiState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, People's Republic of China.
Qian LiDepartment of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang 050000, People's Republic of China.
Lichao LiuDepartment of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang 050000, People's Republic of China.
Yanli ZhangDepartment of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang 050000, People's Republic of China.
Yacong JiDepartment of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang 050000, People's Republic of China.
Leiyang GuoDepartment of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang 050000, People's Republic of China.
Yaling LiuDepartment of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang 050000, People's Republic of China.
Hongjuan CuiState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, People's Republic of China.
Hebei Medical University · CNSouthwest University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
cell cycledehydrocorydalineMAPKmelanomamigration and invasion
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.